← Back to headlines
Scinai Immunotherapeutics receives Nasdaq notice over minimum bid price requirement
Scinai Immunotherapeutics has received a notice from Nasdaq regarding its non-compliance with the minimum bid price requirement.
16 Mar, 20:26 — 16 Mar, 20:26
Sources
Showing 1 of 1 sources
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
P5,000 aid brings relief to 2,959 Tagbilaran tricycle drivers
just now
Cagayan de Oro Transport Workers Receive Fuel Price Aid
just now
Philippines No Longer Southeast Asia's Worst for Fuel Price Hikes, Economic Pain Persists
just now